To the best of our knowledge, this is the first study that focused on the prognostic values of the NLR, CRP/Alb ratio and PLR in patients with Xp11.2 tRCC. The gene discussed is CRP; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.